ATI Heparin - ATI PDF

Preview

Summary

ATI...

Description

ACTIVE LEARNING TEMPLATE:

Medication

Rachel Garcia STUDENT NAME _____________________________________ Heparin- When and how to administer heparin? MEDICATION __________________________________________________________________________

25 in ATI REVIEW MODULE CHAPTER ___________

Anticoagulant CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION

Expected Pharmacological Action prevents conversion of fibrinogen and prothrombin to thrombin by enhancing inhibitory effects of antithrombin III (ATI, p. 191)

Therapeutic Use prevention of DVT, PE, MI, open heart surgery, A-FIB, anticoagulant in dialysis and transfusion procedures, treatment of DIC. (ATI, p. 191)

Complications Hemorrhage, thrombocytopenia, anemia, herperin induced TCP (ATI, p. 191)

Medication Administration IV infusion IV bolus cannot be used interchangeably (unit for unit) with LMWHs or heparinoids. SUBCUT abdomen between pelvic bones, rotate sites.

Contraindications/Precautions

avoid all IM injections that may cause hematoma (ATI, p. 192)

contraindications: bleeding, hypersensitivity precautions: children/elderly, diabetes, renal disease, severe HTN, pregnancy, lactation (ATI, p. 192)

Interactions NSAIDS, aspirin, and other anticoagulants because they can increase the risk of bleeding (ATI, p. 192)

Nursing Interventions platelet count q2-3 days. bleeding, hemorrhage; gums, petechiae, black tarry stools, decrease in hematocrit, check periodically for sign of decreasing clots. PTT, occult blood in stools. (ATI, p. 192)

Client Education Evaluation of Medication Effectiveness prevention of DVT and pulmonary emboli adequate coagulation based on aPTT (ATI, p. 193)

ACTIVE LEARNING TEMPLATES

use soft bristle toothbrush, use electric razor. avoid contact sports. avoid IM inj, carry emergency ID identifying product taken. Report bleeding to provider;gums, under skin, urine, and stools avoid OTC preparations unless directed by provider. notify all HCP of heparin use. (ATI, p. 192)

THERAPEUTIC PROCEDURE

A7...